Massimo Martino: VEN-DEC-GITMO – Advancing AML Treatment in Older Patients
Massimo Martino, President of GITMO, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood Advances, adding:
“Published in Blood Advances (official journal of the American Society of Hematology, ASH):
The Italian multicenter study VEN-DEC-GITMO — ‘A Curative-Intent Treatment Programme in Older AML: Mature Post-Transplant Results from the VEN-DEC-GITMO Study.’
The study involved over 30 Italian hematology centers (GITMO) and confirms that the venetoclax-decitabine combination can serve as an effective ‘bridge to transplant’ for older patients with acute myeloid leukemia, enabling them to reach allogeneic transplant in optimal clinical condition.
2-year results: overall survival of 52.8%, disease-free survival of 50.9%, and a relapse incidence contained at 20.1% — remarkable outcomes for a population with a median age of 68.5 years and high-risk disease.
Among the participating centers, an important contribution came from GOM ‘Bianchi-Melacrino-Morelli‘ in Reggio Calabria, with Massimo Martino and Caterina Alati, reflecting the active role of Calabrian hematology in national and international clinical research.
A further step forward in defining curative-intent treatment pathways for older AML patients.”
Title: A Curative-Intent Treatment Programme in Older AML: Mature Post-Transplant Results from the VEN-DEC-GITMO Study
Authors: Daniele Avenoso, Mirko Farina, Alessandro Leoni, Nicola Polverelli, Simona Bernardi, Stella Santarone, Erika Borlenghi, Francesco Onida, Luca Castagna, Stefania Bramanti, Angelo Michele Carella, Roberto Sorasio, Caterina Alati, Attilio Olivieri, Germana Beltrami, Carmen di Grazia, Antonio Curti, Francesca Bonifazi, Calogero Vetro, Salvatore Leotta, Valentina Mancini, Giovanni Grillo, Elisabetta Terruzzi, Massimo Bernardi, Alessandro Bruno, Piero Galieni, Pellegrino Musto, Raffaella Cerretti, Luisa Giaccone, Cristina Skert, Vera Radici, Marika Vezzoli, Stefano Calza, Luca Garuffo, Cristian Bonvicini, Simone Pellizzeri, Michele Malagola, Massimo Martino, Domenico Russo
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery